Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1207
beforeandafterphotos_vert.jpg

Article ID: 696509

Lethal Prostate Cancer Treatment May Benefit from Combination Immunotherapy

Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer. The study suggested a genetic subset of prostate cancer may benefit from this form of immunotherapy.

Released:
25-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Norrisetal.jpg
  • Embargo expired:
    25-Jun-2018 9:00 AM EDT

Article ID: 696245

Researchers Identify Brain Cells Responsible for Removing Damaged Neurons After Injury

The Rockefeller University Press

Researchers at the University of Virginia School of Medicine have discovered that microglia, specialized immune cells in the brain, play a key role in clearing dead material after brain injury. The study, which will be published June 25 in the Journal of Experimental Medicine, reveals that microglia gobble up the remnants of injured neurons, which could prevent the damage from spreading to neighboring neurons and causing more extensive neurodegeneration.

Released:
19-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Hill_Davis_Headshot_3.jpg

Article ID: 696532

Children with Existing Allergies Should Be Screened for an Emerging, Severe Chronic Food Allergy

Children's Hospital of Philadelphia

Children with known skin, food and respiratory allergies should be screened for an emerging food allergy called eosinophilic esophagitis (EoE), a painful inflammation of the esophagus. Pediatric allergists who analyzed a very large group of children say that EoE is a later component of the “allergic march”-- in which many children successively develop a series of allergies.

Released:
25-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
27-Jun-2018 1:00 PM EDT
Released to reporters:
22-Jun-2018 12:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Jun-2018 1:00 PM EDT

Article ID: 696440

The Immune System: Cracking Open the Black Box

American Technion Society

A technology developed at Israel's Technion will provide the scientific community with novel tools to gain a comprehensive understanding of immune system activity. Based on millions of scientific publications, the technology uses artificial intelligence to map disease immune profiles. These maps, which have already identified previously unknown biological interactions, will enable development of personalized, immuno-centric therapies

Released:
21-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Emergency-large.jpg
  • Embargo expired:
    21-Jun-2018 7:00 AM EDT

Article ID: 696259

Majority of U.S. Adults Prescribed Epinephrine Report Not Using It in an Emergency

American College of Allergy, Asthma and Immunology (ACAAI)

A new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn’t use the epinephrine auto-injectors (EAI) they were prescribed.

Released:
18-Jun-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696368

Scientists Unravel DNA Code Behind Rare Neurologic Disease

UT Southwestern Medical Center

Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

Released:
20-Jun-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696364

Fetal T cells are first responders to infection in adults

Cornell University

Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the body.

Released:
20-Jun-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 696249

Seattle Children's Opens Immunotherapy Trial For Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain

Seattle Children's Hospital

Seattle Children’s has opened a pioneering chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory HER2-positive central nervous system (CNS) tumors where CAR T cells will be delivered directly into the brain. In the phase I trial, BrainChild-01, cancer-fighting CAR T cells will be infused through a catheter, either into the cavity where the tumor has been removed or the CNS ventricular system, depending on the location of the tumor.

Released:
19-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
shutterstock_932892vaccinebullseye.jpg

Article ID: 696263

Exploring a New Treatment for Metastatic Colorectal Cancer

Rutgers Cancer Institute of New Jersey

Researchers at Rutgers Cancer Institute are exploring the combination of a new anti-cancer vaccine with an immunotherapy drug approved for use in other forms of cancer to determine if the combined treatment can prompt a patient’s natural defenses (the immune system) to attack their cancer and improve their survival.

Released:
19-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1207





Chat now!